Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-47,999
Closed -$480K 44
2025
Q3
$480K Sell
47,999
-11,890
-20% -$775K 1.78% 22
2025
Q2
$3.15M Buy
59,889
+24,597
+70% +$1.16M 1.35% 24
2025
Q1
$1.49M Sell
35,292
-27,229
-44% -$1.19M 0.66% 32
2024
Q4
$2.62M Buy
62,521
+11,834
+23% +$568K 1.24% 25
2024
Q3
$2.53M Buy
50,687
+19,850
+64% +$1.04M 1.19% 23
2024
Q2
$1.82M Buy
30,837
+6,512
+27% +$315K 1.11% 22
2024
Q1
$1.1M Hold
24,325
0.67% 35
2023
Q4
$669K Buy
+24,325
New +$568K 0.52% 36
2022
Q4
$4.42K Buy
+286
New +$5.04K 0.01% 51

Other funds holding MRUS

HealthInvest Partners's MRUS Position: Q4 2025 in Review

HealthInvest Partners sold out of Merus (MRUS) in Q4 2025, closing a stake of 47,999 shares — an estimated $480K sold.

HealthInvest Partners first reported a position in MRUS in Q4 2022 and held it in 9 quarters. The position peaked at $3.15M in Q2 2025. 10 funds tracked by Wall St. Rank hold MRUS as of Q4 2025.

  • HealthInvest Partners reported no remaining Merus position as of Q4 2025 after selling out during the quarter.
  • HealthInvest Partners sold 47,999 Merus shares in Q4 2025, an estimated $480K.
  • HealthInvest Partners first reported a position in Merus in Q4 2022 and held it in 9 quarters.
  • HealthInvest Partners's Merus position peaked at $3.15M in Q2 2025.
  • 10 funds tracked by Wall St. Rank held Merus as of Q4 2025.

Based on HealthInvest Partners's 13F filing for Q4 2025, filed 6 Feb 2026.